Barely Significant
← all excerpts

Functional signaling test identifies HER2 negative breast cancer patients who may benefit from c-Met and pan-HER combination therapy.

Cell Commun Signal · 2022 · PMC8742957 · PMID 34998412

Europe PMCDOI
1
hedged sentence
0.0400
closest p · 0.8× alpha
0.0400
boldest claim

The sentences

nominally significantp = 0.04actually significant
The evidence for three populations rather than two is nominally significant as shown in the formal likelihood ratio tests ( p = 0.04; Fig. 2 c).

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.